nodes	percent_of_prediction	percent_of_DWPC	metapath
Gadodiamide—Musculoskeletal discomfort—Alitretinoin—peripheral nervous system neoplasm	0.00108	0.00108	CcSEcCtD
Gadodiamide—Diarrhoea—Topotecan—peripheral nervous system neoplasm	0.00107	0.00107	CcSEcCtD
Gadodiamide—Convulsion—Cisplatin—peripheral nervous system neoplasm	0.00107	0.00107	CcSEcCtD
Gadodiamide—Diarrhoea—Isotretinoin—peripheral nervous system neoplasm	0.00107	0.00107	CcSEcCtD
Gadodiamide—Diarrhoea—Tretinoin—peripheral nervous system neoplasm	0.00107	0.00107	CcSEcCtD
Gadodiamide—Hypotension—Vincristine—peripheral nervous system neoplasm	0.00106	0.00106	CcSEcCtD
Gadodiamide—Paraesthesia—Alitretinoin—peripheral nervous system neoplasm	0.00106	0.00106	CcSEcCtD
Gadodiamide—Hyponatraemia—Epirubicin—peripheral nervous system neoplasm	0.00105	0.00105	CcSEcCtD
Gadodiamide—Renal failure acute—Doxorubicin—peripheral nervous system neoplasm	0.00105	0.00105	CcSEcCtD
Gadodiamide—Dyspnoea—Alitretinoin—peripheral nervous system neoplasm	0.00105	0.00105	CcSEcCtD
Gadodiamide—Diarrhoea—Melphalan—peripheral nervous system neoplasm	0.00105	0.00105	CcSEcCtD
Gadodiamide—Somnolence—Alitretinoin—peripheral nervous system neoplasm	0.00105	0.00105	CcSEcCtD
Gadodiamide—Myalgia—Cisplatin—peripheral nervous system neoplasm	0.00105	0.00105	CcSEcCtD
Gadodiamide—Feeling abnormal—Dactinomycin—peripheral nervous system neoplasm	0.00105	0.00105	CcSEcCtD
Gadodiamide—Ill-defined disorder—Etoposide—peripheral nervous system neoplasm	0.00105	0.00105	CcSEcCtD
Gadodiamide—Anxiety—Cisplatin—peripheral nervous system neoplasm	0.00105	0.00105	CcSEcCtD
Gadodiamide—Gastrointestinal pain—Dactinomycin—peripheral nervous system neoplasm	0.00104	0.00104	CcSEcCtD
Gadodiamide—Hot flush—Doxorubicin—peripheral nervous system neoplasm	0.00104	0.00104	CcSEcCtD
Gadodiamide—Dyspepsia—Alitretinoin—peripheral nervous system neoplasm	0.00104	0.00104	CcSEcCtD
Gadodiamide—Dizziness—Topotecan—peripheral nervous system neoplasm	0.00104	0.00104	CcSEcCtD
Gadodiamide—Discomfort—Cisplatin—peripheral nervous system neoplasm	0.00104	0.00104	CcSEcCtD
Gadodiamide—Musculoskeletal discomfort—Vincristine—peripheral nervous system neoplasm	0.00104	0.00104	CcSEcCtD
Gadodiamide—Migraine—Epirubicin—peripheral nervous system neoplasm	0.00103	0.00103	CcSEcCtD
Gadodiamide—Menopausal symptoms—Doxorubicin—peripheral nervous system neoplasm	0.00103	0.00103	CcSEcCtD
Gadodiamide—Dizziness—Tretinoin—peripheral nervous system neoplasm	0.00103	0.00103	CcSEcCtD
Gadodiamide—Dizziness—Isotretinoin—peripheral nervous system neoplasm	0.00103	0.00103	CcSEcCtD
Gadodiamide—Renal impairment—Doxorubicin—peripheral nervous system neoplasm	0.00102	0.00102	CcSEcCtD
Gadodiamide—Paraesthesia—Vincristine—peripheral nervous system neoplasm	0.00102	0.00102	CcSEcCtD
Gadodiamide—Malaise—Etoposide—peripheral nervous system neoplasm	0.00102	0.00102	CcSEcCtD
Gadodiamide—Fatigue—Alitretinoin—peripheral nervous system neoplasm	0.00102	0.00102	CcSEcCtD
Gadodiamide—Pain—Alitretinoin—peripheral nervous system neoplasm	0.00101	0.00101	CcSEcCtD
Gadodiamide—Abdominal pain—Dactinomycin—peripheral nervous system neoplasm	0.00101	0.00101	CcSEcCtD
Gadodiamide—Body temperature increased—Dactinomycin—peripheral nervous system neoplasm	0.00101	0.00101	CcSEcCtD
Gadodiamide—Anaphylactic shock—Cisplatin—peripheral nervous system neoplasm	0.00101	0.00101	CcSEcCtD
Gadodiamide—Oedema—Cisplatin—peripheral nervous system neoplasm	0.00101	0.00101	CcSEcCtD
Gadodiamide—Anaphylactoid reaction—Doxorubicin—peripheral nervous system neoplasm	0.001	0.001	CcSEcCtD
Gadodiamide—Infection—Cisplatin—peripheral nervous system neoplasm	0.000999	0.000999	CcSEcCtD
Gadodiamide—Vomiting—Topotecan—peripheral nervous system neoplasm	0.000998	0.000998	CcSEcCtD
Gadodiamide—Cardiac failure—Doxorubicin—peripheral nervous system neoplasm	0.000996	0.000996	CcSEcCtD
Gadodiamide—Loss of consciousness—Etoposide—peripheral nervous system neoplasm	0.000992	0.000992	CcSEcCtD
Gadodiamide—Vomiting—Tretinoin—peripheral nervous system neoplasm	0.00099	0.00099	CcSEcCtD
Gadodiamide—Vomiting—Isotretinoin—peripheral nervous system neoplasm	0.00099	0.00099	CcSEcCtD
Gadodiamide—Rash—Topotecan—peripheral nervous system neoplasm	0.00099	0.00099	CcSEcCtD
Gadodiamide—Dermatitis—Topotecan—peripheral nervous system neoplasm	0.000989	0.000989	CcSEcCtD
Gadodiamide—Ataxia—Epirubicin—peripheral nervous system neoplasm	0.000988	0.000988	CcSEcCtD
Gadodiamide—Nervous system disorder—Cisplatin—peripheral nervous system neoplasm	0.000986	0.000986	CcSEcCtD
Gadodiamide—Blood creatinine increased—Epirubicin—peripheral nervous system neoplasm	0.000984	0.000984	CcSEcCtD
Gadodiamide—Headache—Topotecan—peripheral nervous system neoplasm	0.000983	0.000983	CcSEcCtD
Gadodiamide—Rash—Tretinoin—peripheral nervous system neoplasm	0.000982	0.000982	CcSEcCtD
Gadodiamide—Rash—Isotretinoin—peripheral nervous system neoplasm	0.000982	0.000982	CcSEcCtD
Gadodiamide—Tachycardia—Cisplatin—peripheral nervous system neoplasm	0.000981	0.000981	CcSEcCtD
Gadodiamide—Dermatitis—Tretinoin—peripheral nervous system neoplasm	0.000981	0.000981	CcSEcCtD
Gadodiamide—Dermatitis—Isotretinoin—peripheral nervous system neoplasm	0.000981	0.000981	CcSEcCtD
Gadodiamide—Fatigue—Vincristine—peripheral nervous system neoplasm	0.00098	0.00098	CcSEcCtD
Gadodiamide—Convulsion—Etoposide—peripheral nervous system neoplasm	0.000978	0.000978	CcSEcCtD
Gadodiamide—Vomiting—Melphalan—peripheral nervous system neoplasm	0.000977	0.000977	CcSEcCtD
Gadodiamide—Hyponatraemia—Doxorubicin—peripheral nervous system neoplasm	0.000976	0.000976	CcSEcCtD
Gadodiamide—Headache—Isotretinoin—peripheral nervous system neoplasm	0.000975	0.000975	CcSEcCtD
Gadodiamide—Headache—Tretinoin—peripheral nervous system neoplasm	0.000975	0.000975	CcSEcCtD
Gadodiamide—Feeling abnormal—Alitretinoin—peripheral nervous system neoplasm	0.000972	0.000972	CcSEcCtD
Gadodiamide—Pain—Vincristine—peripheral nervous system neoplasm	0.000972	0.000972	CcSEcCtD
Gadodiamide—Hyperhidrosis—Cisplatin—peripheral nervous system neoplasm	0.000972	0.000972	CcSEcCtD
Gadodiamide—Rash—Melphalan—peripheral nervous system neoplasm	0.000969	0.000969	CcSEcCtD
Gadodiamide—Dermatitis—Melphalan—peripheral nervous system neoplasm	0.000968	0.000968	CcSEcCtD
Gadodiamide—Gastrointestinal pain—Alitretinoin—peripheral nervous system neoplasm	0.000965	0.000965	CcSEcCtD
Gadodiamide—Chest pain—Etoposide—peripheral nervous system neoplasm	0.000961	0.000961	CcSEcCtD
Gadodiamide—Migraine—Doxorubicin—peripheral nervous system neoplasm	0.000957	0.000957	CcSEcCtD
Gadodiamide—Discomfort—Etoposide—peripheral nervous system neoplasm	0.000949	0.000949	CcSEcCtD
Gadodiamide—Hypotension—Cisplatin—peripheral nervous system neoplasm	0.00094	0.00094	CcSEcCtD
Gadodiamide—Hypersensitivity—Dactinomycin—peripheral nervous system neoplasm	0.000938	0.000938	CcSEcCtD
Gadodiamide—Urticaria—Alitretinoin—peripheral nervous system neoplasm	0.000937	0.000937	CcSEcCtD
Gadodiamide—Body temperature increased—Alitretinoin—peripheral nervous system neoplasm	0.000933	0.000933	CcSEcCtD
Gadodiamide—Abdominal pain—Alitretinoin—peripheral nervous system neoplasm	0.000933	0.000933	CcSEcCtD
Gadodiamide—Nausea—Topotecan—peripheral nervous system neoplasm	0.000932	0.000932	CcSEcCtD
Gadodiamide—Gastrointestinal pain—Vincristine—peripheral nervous system neoplasm	0.00093	0.00093	CcSEcCtD
Gadodiamide—Nausea—Isotretinoin—peripheral nervous system neoplasm	0.000925	0.000925	CcSEcCtD
Gadodiamide—Nausea—Tretinoin—peripheral nervous system neoplasm	0.000925	0.000925	CcSEcCtD
Gadodiamide—Anaphylactic shock—Etoposide—peripheral nervous system neoplasm	0.000921	0.000921	CcSEcCtD
Gadodiamide—Musculoskeletal discomfort—Cisplatin—peripheral nervous system neoplasm	0.000916	0.000916	CcSEcCtD
Gadodiamide—Infection—Etoposide—peripheral nervous system neoplasm	0.000915	0.000915	CcSEcCtD
Gadodiamide—Ataxia—Doxorubicin—peripheral nervous system neoplasm	0.000914	0.000914	CcSEcCtD
Gadodiamide—Asthenia—Dactinomycin—peripheral nervous system neoplasm	0.000913	0.000913	CcSEcCtD
Gadodiamide—Nausea—Melphalan—peripheral nervous system neoplasm	0.000913	0.000913	CcSEcCtD
Gadodiamide—Blood creatinine increased—Doxorubicin—peripheral nervous system neoplasm	0.000911	0.000911	CcSEcCtD
Gadodiamide—Paraesthesia—Cisplatin—peripheral nervous system neoplasm	0.000903	0.000903	CcSEcCtD
Gadodiamide—Tachycardia—Etoposide—peripheral nervous system neoplasm	0.000899	0.000899	CcSEcCtD
Gadodiamide—Abdominal pain—Vincristine—peripheral nervous system neoplasm	0.000899	0.000899	CcSEcCtD
Gadodiamide—Body temperature increased—Vincristine—peripheral nervous system neoplasm	0.000899	0.000899	CcSEcCtD
Gadodiamide—Dyspnoea—Cisplatin—peripheral nervous system neoplasm	0.000896	0.000896	CcSEcCtD
Gadodiamide—Hyperhidrosis—Etoposide—peripheral nervous system neoplasm	0.000891	0.000891	CcSEcCtD
Gadodiamide—Diarrhoea—Dactinomycin—peripheral nervous system neoplasm	0.000871	0.000871	CcSEcCtD
Gadodiamide—Hypersensitivity—Alitretinoin—peripheral nervous system neoplasm	0.000869	0.000869	CcSEcCtD
Gadodiamide—Hypotension—Etoposide—peripheral nervous system neoplasm	0.000861	0.000861	CcSEcCtD
Gadodiamide—Pain—Cisplatin—peripheral nervous system neoplasm	0.00086	0.00086	CcSEcCtD
Gadodiamide—Asthenia—Alitretinoin—peripheral nervous system neoplasm	0.000847	0.000847	CcSEcCtD
Gadodiamide—Hypersensitivity—Vincristine—peripheral nervous system neoplasm	0.000838	0.000838	CcSEcCtD
Gadodiamide—Pruritus—Alitretinoin—peripheral nervous system neoplasm	0.000835	0.000835	CcSEcCtD
Gadodiamide—Feeling abnormal—Cisplatin—peripheral nervous system neoplasm	0.000829	0.000829	CcSEcCtD
Gadodiamide—Paraesthesia—Etoposide—peripheral nervous system neoplasm	0.000827	0.000827	CcSEcCtD
Gadodiamide—Dyspnoea—Etoposide—peripheral nervous system neoplasm	0.000821	0.000821	CcSEcCtD
Gadodiamide—Somnolence—Etoposide—peripheral nervous system neoplasm	0.000819	0.000819	CcSEcCtD
Gadodiamide—Asthenia—Vincristine—peripheral nervous system neoplasm	0.000816	0.000816	CcSEcCtD
Gadodiamide—Vomiting—Dactinomycin—peripheral nervous system neoplasm	0.000809	0.000809	CcSEcCtD
Gadodiamide—Diarrhoea—Alitretinoin—peripheral nervous system neoplasm	0.000807	0.000807	CcSEcCtD
Gadodiamide—Rash—Dactinomycin—peripheral nervous system neoplasm	0.000802	0.000802	CcSEcCtD
Gadodiamide—Renal failure—Epirubicin—peripheral nervous system neoplasm	0.000796	0.000796	CcSEcCtD
Gadodiamide—Body temperature increased—Cisplatin—peripheral nervous system neoplasm	0.000795	0.000795	CcSEcCtD
Gadodiamide—Fatigue—Etoposide—peripheral nervous system neoplasm	0.000794	0.000794	CcSEcCtD
Gadodiamide—Neuropathy peripheral—Epirubicin—peripheral nervous system neoplasm	0.000794	0.000794	CcSEcCtD
Gadodiamide—Pain—Etoposide—peripheral nervous system neoplasm	0.000788	0.000788	CcSEcCtD
Gadodiamide—Dizziness—Alitretinoin—peripheral nervous system neoplasm	0.00078	0.00078	CcSEcCtD
Gadodiamide—Diarrhoea—Vincristine—peripheral nervous system neoplasm	0.000778	0.000778	CcSEcCtD
Gadodiamide—Feeling abnormal—Etoposide—peripheral nervous system neoplasm	0.000759	0.000759	CcSEcCtD
Gadodiamide—Nausea—Dactinomycin—peripheral nervous system neoplasm	0.000756	0.000756	CcSEcCtD
Gadodiamide—Gastrointestinal pain—Etoposide—peripheral nervous system neoplasm	0.000753	0.000753	CcSEcCtD
Gadodiamide—Dizziness—Vincristine—peripheral nervous system neoplasm	0.000752	0.000752	CcSEcCtD
Gadodiamide—Vomiting—Alitretinoin—peripheral nervous system neoplasm	0.00075	0.00075	CcSEcCtD
Gadodiamide—Rash—Alitretinoin—peripheral nervous system neoplasm	0.000744	0.000744	CcSEcCtD
Gadodiamide—Dermatitis—Alitretinoin—peripheral nervous system neoplasm	0.000743	0.000743	CcSEcCtD
Gadodiamide—Hypersensitivity—Cisplatin—peripheral nervous system neoplasm	0.000741	0.000741	CcSEcCtD
Gadodiamide—Headache—Alitretinoin—peripheral nervous system neoplasm	0.000739	0.000739	CcSEcCtD
Gadodiamide—Renal failure—Doxorubicin—peripheral nervous system neoplasm	0.000736	0.000736	CcSEcCtD
Gadodiamide—Neuropathy peripheral—Doxorubicin—peripheral nervous system neoplasm	0.000734	0.000734	CcSEcCtD
Gadodiamide—Urticaria—Etoposide—peripheral nervous system neoplasm	0.000732	0.000732	CcSEcCtD
Gadodiamide—Rhinitis—Epirubicin—peripheral nervous system neoplasm	0.000729	0.000729	CcSEcCtD
Gadodiamide—Body temperature increased—Etoposide—peripheral nervous system neoplasm	0.000728	0.000728	CcSEcCtD
Gadodiamide—Abdominal pain—Etoposide—peripheral nervous system neoplasm	0.000728	0.000728	CcSEcCtD
Gadodiamide—Vomiting—Vincristine—peripheral nervous system neoplasm	0.000723	0.000723	CcSEcCtD
Gadodiamide—Asthenia—Cisplatin—peripheral nervous system neoplasm	0.000721	0.000721	CcSEcCtD
Gadodiamide—Pharyngitis—Epirubicin—peripheral nervous system neoplasm	0.000721	0.000721	CcSEcCtD
Gadodiamide—Urinary tract disorder—Epirubicin—peripheral nervous system neoplasm	0.000718	0.000718	CcSEcCtD
Gadodiamide—Rash—Vincristine—peripheral nervous system neoplasm	0.000717	0.000717	CcSEcCtD
Gadodiamide—Dermatitis—Vincristine—peripheral nervous system neoplasm	0.000716	0.000716	CcSEcCtD
Gadodiamide—Urethral disorder—Epirubicin—peripheral nervous system neoplasm	0.000712	0.000712	CcSEcCtD
Gadodiamide—Headache—Vincristine—peripheral nervous system neoplasm	0.000712	0.000712	CcSEcCtD
Gadodiamide—Nausea—Alitretinoin—peripheral nervous system neoplasm	0.000701	0.000701	CcSEcCtD
Gadodiamide—Visual impairment—Epirubicin—peripheral nervous system neoplasm	0.0007	0.0007	CcSEcCtD
Gadodiamide—Diarrhoea—Cisplatin—peripheral nervous system neoplasm	0.000688	0.000688	CcSEcCtD
Gadodiamide—Hypersensitivity—Etoposide—peripheral nervous system neoplasm	0.000679	0.000679	CcSEcCtD
Gadodiamide—Tinnitus—Epirubicin—peripheral nervous system neoplasm	0.000678	0.000678	CcSEcCtD
Gadodiamide—Nausea—Vincristine—peripheral nervous system neoplasm	0.000675	0.000675	CcSEcCtD
Gadodiamide—Flushing—Epirubicin—peripheral nervous system neoplasm	0.000675	0.000675	CcSEcCtD
Gadodiamide—Rhinitis—Doxorubicin—peripheral nervous system neoplasm	0.000674	0.000674	CcSEcCtD
Gadodiamide—Pharyngitis—Doxorubicin—peripheral nervous system neoplasm	0.000667	0.000667	CcSEcCtD
Gadodiamide—Urinary tract disorder—Doxorubicin—peripheral nervous system neoplasm	0.000664	0.000664	CcSEcCtD
Gadodiamide—Asthenia—Etoposide—peripheral nervous system neoplasm	0.000661	0.000661	CcSEcCtD
Gadodiamide—Urethral disorder—Doxorubicin—peripheral nervous system neoplasm	0.000659	0.000659	CcSEcCtD
Gadodiamide—Chills—Epirubicin—peripheral nervous system neoplasm	0.000652	0.000652	CcSEcCtD
Gadodiamide—Pruritus—Etoposide—peripheral nervous system neoplasm	0.000652	0.000652	CcSEcCtD
Gadodiamide—Arrhythmia—Epirubicin—peripheral nervous system neoplasm	0.000649	0.000649	CcSEcCtD
Gadodiamide—Visual impairment—Doxorubicin—peripheral nervous system neoplasm	0.000648	0.000648	CcSEcCtD
Gadodiamide—Vomiting—Cisplatin—peripheral nervous system neoplasm	0.000639	0.000639	CcSEcCtD
Gadodiamide—Rash—Cisplatin—peripheral nervous system neoplasm	0.000634	0.000634	CcSEcCtD
Gadodiamide—Dermatitis—Cisplatin—peripheral nervous system neoplasm	0.000633	0.000633	CcSEcCtD
Gadodiamide—Diarrhoea—Etoposide—peripheral nervous system neoplasm	0.00063	0.00063	CcSEcCtD
Gadodiamide—Tinnitus—Doxorubicin—peripheral nervous system neoplasm	0.000627	0.000627	CcSEcCtD
Gadodiamide—Flushing—Doxorubicin—peripheral nervous system neoplasm	0.000624	0.000624	CcSEcCtD
Gadodiamide—Dysgeusia—Epirubicin—peripheral nervous system neoplasm	0.00062	0.00062	CcSEcCtD
Gadodiamide—Dizziness—Etoposide—peripheral nervous system neoplasm	0.000609	0.000609	CcSEcCtD
Gadodiamide—Chills—Doxorubicin—peripheral nervous system neoplasm	0.000603	0.000603	CcSEcCtD
Gadodiamide—Arrhythmia—Doxorubicin—peripheral nervous system neoplasm	0.000601	0.000601	CcSEcCtD
Gadodiamide—Nausea—Cisplatin—peripheral nervous system neoplasm	0.000597	0.000597	CcSEcCtD
Gadodiamide—Ill-defined disorder—Epirubicin—peripheral nervous system neoplasm	0.000587	0.000587	CcSEcCtD
Gadodiamide—Vomiting—Etoposide—peripheral nervous system neoplasm	0.000586	0.000586	CcSEcCtD
Gadodiamide—Rash—Etoposide—peripheral nervous system neoplasm	0.000581	0.000581	CcSEcCtD
Gadodiamide—Dermatitis—Etoposide—peripheral nervous system neoplasm	0.00058	0.00058	CcSEcCtD
Gadodiamide—Headache—Etoposide—peripheral nervous system neoplasm	0.000577	0.000577	CcSEcCtD
Gadodiamide—Dysgeusia—Doxorubicin—peripheral nervous system neoplasm	0.000573	0.000573	CcSEcCtD
Gadodiamide—Malaise—Epirubicin—peripheral nervous system neoplasm	0.000571	0.000571	CcSEcCtD
Gadodiamide—Syncope—Epirubicin—peripheral nervous system neoplasm	0.000567	0.000567	CcSEcCtD
Gadodiamide—Loss of consciousness—Epirubicin—peripheral nervous system neoplasm	0.000556	0.000556	CcSEcCtD
Gadodiamide—Convulsion—Epirubicin—peripheral nervous system neoplasm	0.000548	0.000548	CcSEcCtD
Gadodiamide—Nausea—Etoposide—peripheral nervous system neoplasm	0.000547	0.000547	CcSEcCtD
Gadodiamide—Ill-defined disorder—Doxorubicin—peripheral nervous system neoplasm	0.000543	0.000543	CcSEcCtD
Gadodiamide—Chest pain—Epirubicin—peripheral nervous system neoplasm	0.000539	0.000539	CcSEcCtD
Gadodiamide—Arthralgia—Epirubicin—peripheral nervous system neoplasm	0.000539	0.000539	CcSEcCtD
Gadodiamide—Myalgia—Epirubicin—peripheral nervous system neoplasm	0.000539	0.000539	CcSEcCtD
Gadodiamide—Anxiety—Epirubicin—peripheral nervous system neoplasm	0.000537	0.000537	CcSEcCtD
Gadodiamide—Discomfort—Epirubicin—peripheral nervous system neoplasm	0.000532	0.000532	CcSEcCtD
Gadodiamide—Malaise—Doxorubicin—peripheral nervous system neoplasm	0.000528	0.000528	CcSEcCtD
Gadodiamide—Dry mouth—Epirubicin—peripheral nervous system neoplasm	0.000527	0.000527	CcSEcCtD
Gadodiamide—Syncope—Doxorubicin—peripheral nervous system neoplasm	0.000525	0.000525	CcSEcCtD
Gadodiamide—Oedema—Epirubicin—peripheral nervous system neoplasm	0.000516	0.000516	CcSEcCtD
Gadodiamide—Anaphylactic shock—Epirubicin—peripheral nervous system neoplasm	0.000516	0.000516	CcSEcCtD
Gadodiamide—Loss of consciousness—Doxorubicin—peripheral nervous system neoplasm	0.000515	0.000515	CcSEcCtD
Gadodiamide—Infection—Epirubicin—peripheral nervous system neoplasm	0.000513	0.000513	CcSEcCtD
Gadodiamide—Shock—Epirubicin—peripheral nervous system neoplasm	0.000508	0.000508	CcSEcCtD
Gadodiamide—Convulsion—Doxorubicin—peripheral nervous system neoplasm	0.000507	0.000507	CcSEcCtD
Gadodiamide—Nervous system disorder—Epirubicin—peripheral nervous system neoplasm	0.000506	0.000506	CcSEcCtD
Gadodiamide—Tachycardia—Epirubicin—peripheral nervous system neoplasm	0.000504	0.000504	CcSEcCtD
Gadodiamide—Hyperhidrosis—Epirubicin—peripheral nervous system neoplasm	0.000499	0.000499	CcSEcCtD
Gadodiamide—Arthralgia—Doxorubicin—peripheral nervous system neoplasm	0.000498	0.000498	CcSEcCtD
Gadodiamide—Myalgia—Doxorubicin—peripheral nervous system neoplasm	0.000498	0.000498	CcSEcCtD
Gadodiamide—Chest pain—Doxorubicin—peripheral nervous system neoplasm	0.000498	0.000498	CcSEcCtD
Gadodiamide—Anxiety—Doxorubicin—peripheral nervous system neoplasm	0.000497	0.000497	CcSEcCtD
Gadodiamide—Discomfort—Doxorubicin—peripheral nervous system neoplasm	0.000492	0.000492	CcSEcCtD
Gadodiamide—Dry mouth—Doxorubicin—peripheral nervous system neoplasm	0.000487	0.000487	CcSEcCtD
Gadodiamide—Hypotension—Epirubicin—peripheral nervous system neoplasm	0.000482	0.000482	CcSEcCtD
Gadodiamide—Oedema—Doxorubicin—peripheral nervous system neoplasm	0.000478	0.000478	CcSEcCtD
Gadodiamide—Anaphylactic shock—Doxorubicin—peripheral nervous system neoplasm	0.000478	0.000478	CcSEcCtD
Gadodiamide—Infection—Doxorubicin—peripheral nervous system neoplasm	0.000475	0.000475	CcSEcCtD
Gadodiamide—Musculoskeletal discomfort—Epirubicin—peripheral nervous system neoplasm	0.00047	0.00047	CcSEcCtD
Gadodiamide—Shock—Doxorubicin—peripheral nervous system neoplasm	0.00047	0.00047	CcSEcCtD
Gadodiamide—Nervous system disorder—Doxorubicin—peripheral nervous system neoplasm	0.000469	0.000469	CcSEcCtD
Gadodiamide—Tachycardia—Doxorubicin—peripheral nervous system neoplasm	0.000466	0.000466	CcSEcCtD
Gadodiamide—Paraesthesia—Epirubicin—peripheral nervous system neoplasm	0.000464	0.000464	CcSEcCtD
Gadodiamide—Hyperhidrosis—Doxorubicin—peripheral nervous system neoplasm	0.000462	0.000462	CcSEcCtD
Gadodiamide—Dyspnoea—Epirubicin—peripheral nervous system neoplasm	0.00046	0.00046	CcSEcCtD
Gadodiamide—Somnolence—Epirubicin—peripheral nervous system neoplasm	0.000459	0.000459	CcSEcCtD
Gadodiamide—Dyspepsia—Epirubicin—peripheral nervous system neoplasm	0.000455	0.000455	CcSEcCtD
Gadodiamide—Hypotension—Doxorubicin—peripheral nervous system neoplasm	0.000446	0.000446	CcSEcCtD
Gadodiamide—Fatigue—Epirubicin—peripheral nervous system neoplasm	0.000445	0.000445	CcSEcCtD
Gadodiamide—Pain—Epirubicin—peripheral nervous system neoplasm	0.000442	0.000442	CcSEcCtD
Gadodiamide—Musculoskeletal discomfort—Doxorubicin—peripheral nervous system neoplasm	0.000435	0.000435	CcSEcCtD
Gadodiamide—Paraesthesia—Doxorubicin—peripheral nervous system neoplasm	0.000429	0.000429	CcSEcCtD
Gadodiamide—Dyspnoea—Doxorubicin—peripheral nervous system neoplasm	0.000426	0.000426	CcSEcCtD
Gadodiamide—Feeling abnormal—Epirubicin—peripheral nervous system neoplasm	0.000426	0.000426	CcSEcCtD
Gadodiamide—Somnolence—Doxorubicin—peripheral nervous system neoplasm	0.000425	0.000425	CcSEcCtD
Gadodiamide—Gastrointestinal pain—Epirubicin—peripheral nervous system neoplasm	0.000422	0.000422	CcSEcCtD
Gadodiamide—Dyspepsia—Doxorubicin—peripheral nervous system neoplasm	0.000421	0.000421	CcSEcCtD
Gadodiamide—Fatigue—Doxorubicin—peripheral nervous system neoplasm	0.000412	0.000412	CcSEcCtD
Gadodiamide—Urticaria—Epirubicin—peripheral nervous system neoplasm	0.00041	0.00041	CcSEcCtD
Gadodiamide—Pain—Doxorubicin—peripheral nervous system neoplasm	0.000409	0.000409	CcSEcCtD
Gadodiamide—Body temperature increased—Epirubicin—peripheral nervous system neoplasm	0.000408	0.000408	CcSEcCtD
Gadodiamide—Abdominal pain—Epirubicin—peripheral nervous system neoplasm	0.000408	0.000408	CcSEcCtD
Gadodiamide—Feeling abnormal—Doxorubicin—peripheral nervous system neoplasm	0.000394	0.000394	CcSEcCtD
Gadodiamide—Gastrointestinal pain—Doxorubicin—peripheral nervous system neoplasm	0.000391	0.000391	CcSEcCtD
Gadodiamide—Hypersensitivity—Epirubicin—peripheral nervous system neoplasm	0.00038	0.00038	CcSEcCtD
Gadodiamide—Urticaria—Doxorubicin—peripheral nervous system neoplasm	0.00038	0.00038	CcSEcCtD
Gadodiamide—Body temperature increased—Doxorubicin—peripheral nervous system neoplasm	0.000378	0.000378	CcSEcCtD
Gadodiamide—Abdominal pain—Doxorubicin—peripheral nervous system neoplasm	0.000378	0.000378	CcSEcCtD
Gadodiamide—Asthenia—Epirubicin—peripheral nervous system neoplasm	0.00037	0.00037	CcSEcCtD
Gadodiamide—Pruritus—Epirubicin—peripheral nervous system neoplasm	0.000365	0.000365	CcSEcCtD
Gadodiamide—Diarrhoea—Epirubicin—peripheral nervous system neoplasm	0.000353	0.000353	CcSEcCtD
Gadodiamide—Hypersensitivity—Doxorubicin—peripheral nervous system neoplasm	0.000352	0.000352	CcSEcCtD
Gadodiamide—Asthenia—Doxorubicin—peripheral nervous system neoplasm	0.000343	0.000343	CcSEcCtD
Gadodiamide—Dizziness—Epirubicin—peripheral nervous system neoplasm	0.000341	0.000341	CcSEcCtD
Gadodiamide—Pruritus—Doxorubicin—peripheral nervous system neoplasm	0.000338	0.000338	CcSEcCtD
Gadodiamide—Vomiting—Epirubicin—peripheral nervous system neoplasm	0.000328	0.000328	CcSEcCtD
Gadodiamide—Diarrhoea—Doxorubicin—peripheral nervous system neoplasm	0.000327	0.000327	CcSEcCtD
Gadodiamide—Rash—Epirubicin—peripheral nervous system neoplasm	0.000326	0.000326	CcSEcCtD
Gadodiamide—Dermatitis—Epirubicin—peripheral nervous system neoplasm	0.000325	0.000325	CcSEcCtD
Gadodiamide—Headache—Epirubicin—peripheral nervous system neoplasm	0.000323	0.000323	CcSEcCtD
Gadodiamide—Dizziness—Doxorubicin—peripheral nervous system neoplasm	0.000316	0.000316	CcSEcCtD
Gadodiamide—Nausea—Epirubicin—peripheral nervous system neoplasm	0.000307	0.000307	CcSEcCtD
Gadodiamide—Vomiting—Doxorubicin—peripheral nervous system neoplasm	0.000304	0.000304	CcSEcCtD
Gadodiamide—Rash—Doxorubicin—peripheral nervous system neoplasm	0.000301	0.000301	CcSEcCtD
Gadodiamide—Dermatitis—Doxorubicin—peripheral nervous system neoplasm	0.000301	0.000301	CcSEcCtD
Gadodiamide—Headache—Doxorubicin—peripheral nervous system neoplasm	0.000299	0.000299	CcSEcCtD
Gadodiamide—Nausea—Doxorubicin—peripheral nervous system neoplasm	0.000284	0.000284	CcSEcCtD
